Robbins Arroyo LLP Is Investigating Regeneron Pharmaceuticals, Inc. (REGN) Officials on Behalf of Shareholders

SAN DIEGO and TARRYTOWN, N.Y., July 1, 2015 /PRNewswire/ -- Shareholder rights attorneys at Robbins Arroyo LLP are investigating whether certain officers and directors of Regeneron Pharmaceuticals, Inc. REGN breached their fiduciary duties to shareholders. Regeneron Pharmaceuticals develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide.

View this press release on the law firm's Shareholder Rights Blog: www.robbinsarroyo.com/shareholders-rights-blog/regeneron-pharmaceuticals-inc  

Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Darnell R. Donahue at (800) 350-6003, DDonahue@robbinsarroyo.com, or via the shareholder information form on the firm's website.

Robbins Arroyo LLP is a nationally recognized leader in securities litigation and shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. For more information, please go to www.robbinsarroyo.com.  

Attorney Advertising. Past results do not guarantee a similar outcome.  

Contact:
Darnell R. Donahue
Robbins Arroyo LLP
DDonahue@robbinsarroyo.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsarroyo.com

Logo - http://photos.prnewswire.com/prnh/20130103/MM36754LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/robbins-arroyo-llp-is-investigating-regeneron-pharmaceuticals-inc-regn-officials-on-behalf-of-shareholders-300107836.html

SOURCE Robbins Arroyo LLP